Cargando…

Immunity status against poliomyelitis in young migrants: a seroprevalence study

Background and aim of the work: Recent seroprevalence studies in different population groups have shown low antibody titers against poliomyelitis, especially in young adults. This, together with the reduction of vaccination rates, could favor the reintroduction of poliovirus in long-time polio-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Veronesi, Licia, Colucci, Maria Eugenia, Capobianco, Emanuela, Bracchi, Maria Teresa, Zoni, Roberta, Palandri, Lucia, Affanni, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233651/
https://www.ncbi.nlm.nih.gov/pubmed/31517887
http://dx.doi.org/10.23750/abm.v90i9-S.8700
_version_ 1783535582437179392
author Veronesi, Licia
Colucci, Maria Eugenia
Capobianco, Emanuela
Bracchi, Maria Teresa
Zoni, Roberta
Palandri, Lucia
Affanni, Paola
author_facet Veronesi, Licia
Colucci, Maria Eugenia
Capobianco, Emanuela
Bracchi, Maria Teresa
Zoni, Roberta
Palandri, Lucia
Affanni, Paola
author_sort Veronesi, Licia
collection PubMed
description Background and aim of the work: Recent seroprevalence studies in different population groups have shown low antibody titers against poliomyelitis, especially in young adults. This, together with the reduction of vaccination rates, could favor the reintroduction of poliovirus in long-time polio-free countries. Within the Surveillance system of acute flaccid paralysis, a prevalence study was conducted to estimate the immunological status associated with poliomyelitis in young migrants. Methods: Local Health Authority collected serum samples in young migrants, without vaccination documentation. Antibodies levels were assessed with a long incubation neutralization assay. Subjects were stratified by age and by WHO region. Seroprotection was defined by a titer equal or above 1:8 and titers > 1:2 were log-transformed and evaluated as geometric mean titers (GMTs). Results: From January 2004 to August 2017, 1138 blood samples were collected. Mean age was 13.3 years with no differences between WHO regions. The percentage of antibody titers below 1:8 was 6.0% versus poliovirus 1 (PV1), 7.7% versus poliovirus 2 (PV2) and 15% versus poliovirus 3 (PV3). The GMTs were 45.5, 29.5 and 20 towards PV1, PV2 and PV3 respectively. In each WHO region, the GMTs towards PV3 were consistently the lowest, and the Europeans showed the lowest GMTs both towards PV2 and PV3 (27.5 and 15.3 respectively). GMTs decreased with age. Conclusion: The low GMTs and the clear tendency to decrease with increasing age of the subjects, especially against to PV1, confirm the framework of attention that polio is receiving at national and international level. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-7233651
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-72336512020-05-19 Immunity status against poliomyelitis in young migrants: a seroprevalence study Veronesi, Licia Colucci, Maria Eugenia Capobianco, Emanuela Bracchi, Maria Teresa Zoni, Roberta Palandri, Lucia Affanni, Paola Acta Biomed Original Article Background and aim of the work: Recent seroprevalence studies in different population groups have shown low antibody titers against poliomyelitis, especially in young adults. This, together with the reduction of vaccination rates, could favor the reintroduction of poliovirus in long-time polio-free countries. Within the Surveillance system of acute flaccid paralysis, a prevalence study was conducted to estimate the immunological status associated with poliomyelitis in young migrants. Methods: Local Health Authority collected serum samples in young migrants, without vaccination documentation. Antibodies levels were assessed with a long incubation neutralization assay. Subjects were stratified by age and by WHO region. Seroprotection was defined by a titer equal or above 1:8 and titers > 1:2 were log-transformed and evaluated as geometric mean titers (GMTs). Results: From January 2004 to August 2017, 1138 blood samples were collected. Mean age was 13.3 years with no differences between WHO regions. The percentage of antibody titers below 1:8 was 6.0% versus poliovirus 1 (PV1), 7.7% versus poliovirus 2 (PV2) and 15% versus poliovirus 3 (PV3). The GMTs were 45.5, 29.5 and 20 towards PV1, PV2 and PV3 respectively. In each WHO region, the GMTs towards PV3 were consistently the lowest, and the Europeans showed the lowest GMTs both towards PV2 and PV3 (27.5 and 15.3 respectively). GMTs decreased with age. Conclusion: The low GMTs and the clear tendency to decrease with increasing age of the subjects, especially against to PV1, confirm the framework of attention that polio is receiving at national and international level. (www.actabiomedica.it) Mattioli 1885 2019 2019-09-13 /pmc/articles/PMC7233651/ /pubmed/31517887 http://dx.doi.org/10.23750/abm.v90i9-S.8700 Text en Copyright: © 2019 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Veronesi, Licia
Colucci, Maria Eugenia
Capobianco, Emanuela
Bracchi, Maria Teresa
Zoni, Roberta
Palandri, Lucia
Affanni, Paola
Immunity status against poliomyelitis in young migrants: a seroprevalence study
title Immunity status against poliomyelitis in young migrants: a seroprevalence study
title_full Immunity status against poliomyelitis in young migrants: a seroprevalence study
title_fullStr Immunity status against poliomyelitis in young migrants: a seroprevalence study
title_full_unstemmed Immunity status against poliomyelitis in young migrants: a seroprevalence study
title_short Immunity status against poliomyelitis in young migrants: a seroprevalence study
title_sort immunity status against poliomyelitis in young migrants: a seroprevalence study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233651/
https://www.ncbi.nlm.nih.gov/pubmed/31517887
http://dx.doi.org/10.23750/abm.v90i9-S.8700
work_keys_str_mv AT veronesilicia immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy
AT coluccimariaeugenia immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy
AT capobiancoemanuela immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy
AT bracchimariateresa immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy
AT zoniroberta immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy
AT palandrilucia immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy
AT affannipaola immunitystatusagainstpoliomyelitisinyoungmigrantsaseroprevalencestudy